Issue date: July 2009.
"The guidance was developed using the NICE single technology appraisal process."
Publisher's number: N1912.
Rituximab for the first-line treatment of chronic lymphocytic leukaemia by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2009. Publication and catalogue information, links to buy online and reader comments.